newsfilter
← Latest News
FDA Approved Drugs·

Approval of Pavblu, Bla #761298

Approval Date: 10/23/2026; Drug Name: Pavblu, Bla #761298; Active Ingredients: AFLIBERCEPT-AYYH; Company: Amgen Inc; Submission Status: Approval; Application Number: 761298

Company
AMGEN INC
Keywords
AMGEN INC